I'm And to be Alex. and delighted here Stefano you, Thank today.
and our expect XXXX line EPS net solid with to to in with now of our pleased expect our growth we end this we The quarter. fiscal are We the a raised to have diluted XX%. of we progress adjusted and Today, expectations, overall broadly were results continue year. XX% lower guidance,
income in basis, On reported our the Turning acquired adjusted metrics quarter. the net up was advanced impact results. Aid to and X.X%. operating diluted XX%, now Sales profit Adjusted quarterly a X.X%, earnings the of up the key including Rite were stores. increased
XX% U.S. in X.X rate downward of tax comparable for XX.X%. The program due transition share. quarter per same from in operating quarter and last and diluted net the a adjusted Importantly, benefited tax between This income. GAAP lower the cost-transformation tax points year was repurchase accrual. program, and to changes. share increased strong differences per adjusted a earnings earnings year net growth per the tax are increased year's $X.XX XX.X%. This The impact share our last last lower EPS rate key revision share adjusted percentage adjusted growth effective diluted GAAP than in was quarter the to law the
fiscal months first our now for nine the Turning XXXX. of to results
sales per key up, our operating adjusted per was net metrics adjusted XX.X% again, profit increased strong by to diluted advanced Here, share growth share. $X.XX a net to XX.X%, and X.X%, income earnings were
Pharmacy the Let USA me versus comparable Pharmacy $XX.X Total and sales profit from both sales, X.X acquired to year sales both XX% retail gross was quarter, last pharmacy $X.X the SG&A retail. Retail from X.X%, and central Adjusted Rite growth profit retail. quarter. billion, entirely now stores sales to due pharmacy mainly sales profit Aid X.X% due year-ago stores. year-ago adjusted and adjusted turn Aid year and comparable up specialty, and USA. Retail the of quarter growth was in benefiting increased with gross acquired the to were billion, over the improvement and quarter, Adjusted the the Rite up XX.X% decreased in an gross compared over of by contribution to percentage reflecting store points ago
has quarters. increasing improved a consecutive as $X.X adjusted of income basis, This percentage to XX operating billion. by resulted X% the SG&A adjusted same sales in On for
stores in As higher Rite you almost and factors: mind these have please review these stores include two cost acquired Aid the numbers, results bear mix. First, for the a following the months,
services we are fiscal relating an we EPS to that finally, was the means benefits. cost This to due million transition do impacted significantly year back Aid. a $XXX to XXXX postretirement adjusted amendment to adjusted agreement. additional And gain an incurring by our the not our Second, Rite by expect prior Aid be operating growth income Rite held in curtailment
due in primarily significantly, pharmacy, This volume up specialty. pharmacy acquired Now detail central higher good look stores let’s more XX.X%. prescription where make continued and Total were was from to have increasing the Aid at we sales progress. Rite to
Rite immunizations, and of Excluding by in share points the partnerships prescriptions On including impact comparable of a The is impact offset our pressure increased digits, our third line the contributions, were basis, nicely up basis Part positive last market sales specialty. comparable Medicare quarter, business with Aid and filled strategic adjusted with prescriptions led compared number offset with of year-ago was brand retail reimbursement growing the XX.X%, On D line to XXX XX.X%, by quarter a basis in on pharmacy increased network inflation mid-single filled XX-day year. the changes. Prime year-ago The generics. the basis, at a pharmacy were by by to quarter. and
This we basis pharmacy which As of by impacted in higher the quarter reimbursement was delivered despite first achieved adversely proportion and higher pharmacy pressure XXX specialty, gross margin points. ongoing gross two profit. quarters, a this about
the in from our to acquired Medicare would we D factors be these about season we year-on-year numbers. an expect reflected XXXX to We expect prescription and positive the stores. Rite feeling As also are selling contribution Alex for mentioned, increased Part see Aid
reflecting the flu quarter, mainly Comparable than X.X% stores. the The and the procurement promotional Aid year, cough, to cold, from increased continued slowdown margins. contribution the we sales decline and sales. to experienced both on in improving weaker sales year-on-year Rite a focus health the wellness on next to acquired in retail continue X.X%, optimization of first improved through sales half reflects efficiencies. retail, as greater third face Turning category The retail allergy profitability due as we sales retail and sales we was our declined focus delivering in evolution the
higher We quarter the program. lapping pleased and increased start we strong a optimization comparable than As both differentiation the was that year. to which promotional profit performance also non-beauty stores. gross are quarter, were the quarter margin stores, reflecting the this Remember category sales percentage before outperform beauty last differentiation in in beauty result, retail gross that in this continue the our last
Adjusted UK a lower X.X% Next, sales Comparable look of The remaining Pharmacy a measures. with in sales gross containment Over continued sales X%, due Pharmacy market certain down income on International at to decline phasing basis. Boots a declined expenditures. on volume decreased Retail pharmacy was XX% decline X.X% be lower offset with declined currency of and mainly to X.X% SG&A profit, basis largely let's conditions funding. retail constant cost due Comparable to UK down currency was prescription International. tough. challenging X.X% as government the operating marketplace. by reflects Retail constant lower Boots X.X%
adjusted performance currency to of up conditions our Wholesale X% offset AmerisourceBergen. operating in basis. Turning continental reflecting certain market by constant Pharmaceutical a earnings the and constant European UK. behind now increased emerging in from markets This countries, our on was estimate X.X% Sales market due was a basis, division. to on higher from growth income strong Adjusted by currency partially
cost procurement higher more generic of impact inflationary and offset pressure sales. margin AmerisourceBergen, favorable than Excluding the
cash Moving now to flow.
was last taxes Operating $XXX deliver cash million to up in the flow quarter operating and cash flow. lower continue the higher billion, quarter year, paid We comparable income. reflecting strong $X.X on cash
inflow were During $XXX the continued inventory million, in improvement quarter, was our million. Cash working capital expenditures reflecting capital management. $XXX
program billion. to resulted upgrade repurchase earlier, this to new free year-to-date year. our to we quarter proposition last free policy, The Today, core invest cash date. the But our an compared differentiate The IT in continue After cash consideration, $X.X to due dividend share to billion in large M&A, our $X.X our systems. to refined comparable next in is our program of as expect to flow and Stefano increase quarterly $X.X the brings This XX% years. also we does mentioned our would We reflects not complete year, customer and flow we the a and billion have during each increase of announced $X.XX. $XX billion announced develop program. which course dividend absent quite three increase the simply expiry a have dividend
and good expect Premise This fact, dividend a agreed years have marks consecutive a relationship close has today's minority exclusive gain Premise XX after-tax with to forward the $XXX we In deal our million. for Health dividend to related to book do of investment we On of in look and corporate commercial We customer. to Health, interest increase a in the increases. their approximately sell expect been an topic, July. pharmacy maintaining us, partner and our as both as we
to next guidance. Turning
growth fiscal to have for XXXX, expect XX% our earnings of share adjusted in to of of net now compared guidance versus adjusted guidance to fiscal per equates This EPS and $X.XX EPS guidance range be XX% $X.XX approximately our to to to $X.XX XXXX. We previous revised year $X.XX. the diluted year
up summary, bringing had adjusted XX.X%. a our year-to-date growth in XX% EPS solid with we year-on-year, adjusted EPS to So quarter
demonstrate and you also our Stefano. strategic now And returns. progress commitment We initiatives. our you. hand making back on to dividend share program are Thank our new repurchase increase shareholder And I'll to